Pharmaceuticals: signature of a MoU to develop a clinical trial ecosystem

Pharmaceuticals: signature of a MoU to develop a clinical trial ecosystem
Pharmaceuticals: signature of a MoU to develop a clinical trial ecosystem

Signing of a multilateral Memorandum of Understanding in the areas of galenic development and clinical trials.

This Friday, the Ministry of Health and Social Protection, that of Industry and Commerce signed a memorandum of understanding with Sothema, Dassault Systems (Americas Corp), the Baylor College of Medicine (USA, Taxas) and Regenlab. An agreement that lays the foundations for a new public-private partnership aimed at strengthening the national pharmaceutical policy “, specify sources consulted by The Desk.

The objective of this partnership one of a kind “, add the same sources, is to allow the emergence of the ” first ecosystem on an African scale specialized in galenic development (CDMO) and clinical trials (CRO) using new technologies and artificial intelligence in order to accelerate the innovation and development of drugs including anti-cancer drugs “.

More concretely, under this agreement, the signatories of this memorandum undertake to “strengthen Morocco’s achievements in public health preparedness and response to epidemics and other health issues, to provide enabling technologies for the digitization of drug development and clinical trials in Morocco. Moreover, these same partners will join efforts in order to designing, implementing and supporting the management of hospitals and health systems, advising on best practices in international standards for cancer care and clinical trials, and developing and manufacturing devices medical for several fields “.

It should also be noted that this memorandum is based, in addition to the signatory parties, on close collaborations with Long Island University (United States, New York) and the Food and Drug Administration (FDA) through an FDA Center of Excellence in Regulatory Science and Innovation (CERSI).

As part of both the national strategy aimed at strengthening the kingdom’s health sovereignty, as well as the country’s industrial development projects, this partnership, underline the same sources, marks a new stage for the industry. pharmaceutical in Morocco.

©️Copyright Pulse Media. All rights reserved.
Reproduction and distribution prohibited (photocopies, intranet, web, messaging, newsletters, monitoring tools) without written authorization


#Morocco

-

-

PREV Dental center hit by buckshot, shooter flees
NEXT CPME 56, the advocate for small and medium-sized enterprises in Morbihan